First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress

• Main Authors: Zhangfeng Huang (Author), Wenhao Su (Author), Tong Lu (Author), Yuanyong Wang (Author), Yanting Dong (Author), Yi Qin (Author), Dahai Liu (Author), Lili Sun (Author), Wenjie Jiao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lung cancer is one of the most common cancers and the leading cause of cancer-related deaths worldwide. Most of these patients with non-small cell lung cancer (NSCLC) present with the advanced stage of the disease at the time of diagnosis, and thus decrease the 5-year survival rate to about 5%. Immu...